Natco Pharma Boosts eGenesis Investment to $22M for Transplants
August 25, 2026 14:06
Natco Pharma invests $14M (total $22M) in eGenesis Inc., a US biotech firm. eGenesis pioneers genome engineering for transplantable organs, addressing the global organ shortage.